







| Apolipoprotein A-I (Apo A-I) | |||
| Request package insert information |
|||
| Product Features The assay kit has a linear range of 1.44 - 250 mg/dL and good correlation with an existing FDA approved product with r2 values >0.98. The Diazyme Apo A-I Assay is not interfered by the following substances at the indicated concentrations: triglycerides at 1000 mg/dL, ascorbic acid at 10 mM, bilirubin at 40 mg/dL, bilirubin conjugate at 40 mg/dL, and hemoglobin at 1000 mg/dL. The reagent is stable for 18 months when stored @ 2°-8°C. |
|||
Assay PrincipleThis method is based on the reaction of a sample containing human Apo A-I and a specific antiserum to form an insoluble complex which can be measured turbidimetrically at 340 nm. By constructing a standard curve from the absorbance of standards the concentration of Apo A-I in the sample can be determined. |
|||
| Intended use For the quantitative in vitro determination of apolipoprotein A-I (apo A-I) in serum. For use as an aid for assessing the risk of coronary artery disease. |
|||
| Product | Catalog Number | Packaging | Method/Format |
| Kit (1120 Tests) | DZ141A-K | R1: 4 x 70 mL R2: 2 x 50 mL |
Immunoturbidimetric Liquid Stable |
| Calibrator | DZ141A-Cal | 1 x 1 mL | |
| Control | DZ130A-Con | 2 x 3 mL | |
©General Atomics All Rights Reserved
Legal Information
